Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...
Timing is everything, right? Diabetes educators explain when they eat their first meal to manage their blood sugars.
A recent study from Western Sydney University has shown that a simple change in how healthcare providers manage type 2 ...
In August 2023, the U.S. Department of Health and Human Services announced the first 10 drugs covered under Medicare Part D ...
As Novo Nordisk rakes in billions, Sen. Bernie Sanders and public health advocates demand answers on why U.S. patients are charged sky-high prices for life-saving drugs like Ozempic while generics ...
Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with ...
In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...
Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.
The U.S. FDA cleared Senseonic Holdings Inc.’s Eversense 365, the first continuous glucose monitor to last a full year with a single sensor rather than the 10 days to two weeks typical for wearable ...
Nearly 4.4 million adult New Yorkers, or 30%, has obesity, but access to weight-loss medications varies based on a variety of ...
In a move aimed at supporting individuals managing diabetes, Diabetics Trust has unveiled an extensive range of diabetic test ...
Karla Robinson, MD and Medical Editor at GoodRx discusses how GLP-1 receptor agonists work and their benefits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback